TBPH
Theravance Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · KY
$17.03
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- 5.89x
- P/E 2026E
- 5.89x
- P/E 2027E
- 9.13x
- P/E 2028E
- 11.20x
- P/S forward
- 8.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.01x
- PEG TTM
- 0.09x
- Price / book
- 3.05x
- Price / sales
- 8.48x
- Price / cash flow
- 17.06x
Enterprise value
- Enterprise value
- $535.1M
- EV / sales
- 5.13x
- EV / EBITDA
- 7.79x
- EV / EBIT
- 114.92x
- Market cap
- $884.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026